US Patent Granted for InQpharm's Litramine™ Technology
SALT LAKE CITY, Sept. 30, 2015 /PRNewswire/ -- InQpharm Group proudly announces the grant of patent No. US 9,107,441 B2 issued for an improved formulation of its Litramine™ technology in the United States.
This invention relates to compositions for reducing the absorption or bioavailability of lipids in the gastrointestinal tract, and to methods for the preparation and use of these compositions. The compositions comprise a source of dietary plant fibers together with cyclodextrin for use in weight management programs that include healthy eating.
"This latest patent further evidences our commitment to continuously innovate and provide a safe, alternate means of healthy weight management. Our innovative products are investigated in state-of-the-art clinical studies to test for effectiveness, reliability and safety before any market introduction," said David Mastroianni, Managing Director of InQpharm North America.
This patent is the latest addition to InQpharm Group's intellectual property portfolio of more than twenty patents applied, in-licensed, and acquired. In order to safeguard the company's key product categories in weight wellness, allergy protection, gastrointestinal health and new benefit categories, InQpharm will continue to invest significantly in the development of patent-protected products meeting modern consumer needs.
Demand for innovations addressing obesity and overweight continues to be high. Body weight management has become a key element of modern healthcare, and consumers are increasingly seeking more effective means of weight reduction. To be able to serve requests for such products in the North American market, InQpharm opened its office in Salt Lake City, Utah, in May 2015.
"InQpharm's product made with Litramine™ technology and other clinically proven effective weight management products will launch in the United States at the end of this year under the bmiSMART™ brand, and will be available for retail distribution and licensing opportunities in early 2016," said Mastroianni. "We expect American consumers will embrace safe, effective weight management aids based on natural fibers and nature-derived actives, as they have in Europe where products made with Litramine™ technology and bmiSMART™ have been the #1 product in the weight loss category for the past 4 years."
InQpharm is a global life sciences-based company that develops natural healthcare products by combining Science, Nature, and Technology. InQpharm delivers innovative solutions that nourish, protect, and improve lives in the global consumer and animal health arenas. Founded in 2005 in Kuala Lumpur, the company has grown to include offices in Berlin, Netherlands, United Kingdom, and in the United States. InQpharm facilities around the globe provide end-to-end services from idea generation and research and development to commercialization of products.
For more information please visit www.inqpharm.com.
David Mastroianni Managing Director InQpharm North America
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/us-patent-granted-for-inqpharms-litramine-technology-300151582.html